In this report, the effect of flufenamic acid on voltage-activated transient outward K ϩ current (I A ) in cultured rat cerebellar granule cells was investigated. At a concentration of 20 M to 1 mM, flufenamic acid reversibly inhibited I A in a dose-dependent manner. However, flufenamic acid at a concentration of 0.1 to 10 M significantly increased the current amplitude of I A . In addition to the current amplitude of I A , a higher concentration of flufenamic acid had a significant effect on the kinetic parameters of the steady-state activation and inactivation process, suggesting that the binding affinity of flufenamic acid to I A channels may be state-dependent. Silencing the K v 4.2, K v 4.3, and K v 1.1 genes of I A channels using small interfering RNA did not change the inhibitory effect of flufenamic on I A , indicating that flufenamic acid did not act specifically on any of the subunits of the I A -channel protein. Intracellular application of flufenamic acid could significantly increase the I A amplitude but did not alter the inhibited effect induced by extracellular application of flufenamic acid, implying that flufenamic acid may exert its effect from both the inside and outside sites of the channel. Furthermore, the activation of current induced by intracellular application of flufenamic acid could mimic other cyclooxygenase inhibitors and arachidonic acid. Our data are the first that demonstrate how flufenamic acid is able to bidirectionally modulate I A channels in neurons at different concentrations and by different methods of application and that two different mechanisms may be involved.
Nonsteroidal anti-inflammatory drugs (NSAIDs) play essential roles as anti-inflammatory, analgesic, and antipyretic drugs. The fenamate NSAIDs-such as meclofenamic, flufenamic, mefenamic, and niflumic acids-are all derivatives of N-phenylanthranilic acid and are the most common NSAIDs used to reduce inflammation and pain associated with arthritis (Dawood, 1993; Alves and Duarte, 2002) . In addition, the potential effects of NSAIDs on the central nervous system, such as neuroprotection in Alzheimer's disease, have instigated several basic and clinical studies (Rich et al., 1995) . It is well known that the major mechanism mediating the antiinflammatory effects of fenamate and other NSAIDs is inhibition of cyclooxygenase, resulting in decreased prostaglandin formation (Vane, 1996) On the other hand, the effects of fenamate NSAIDs on different ion channels have been studied widely. It has been shown that local administration of voltage-dependent or Ca 2ϩ -activated K ϩ channel blockers could prevent the fenamate-induced peripheral antinociception, suggesting that fenamate may open several K ϩ channels at the primary afferent neurons (Alves and Duarte, 2002) . In the trabecular meshwork of the eye, flufenamic acid enhances current through maxi-K channels (Stumpff et al., 2001 ). In addition, activation and inhibition of CLC-K channels (kidney CLC chloride channels) by distinct binding sites of niflumic acid and fenamate acid has been reported by Liantonio et al. (2006) . However, the effect of fenamate NSAIDs on ion channels was considered to directly block ion channels, and few report were concerned with the main mechanism that mediates fenamate-induced inhibition of cyclooxygenase.
It has been shown that cerebellar granule cells grown in primary culture have two main voltage-activated outward K ϩ currents: rectify outward K ϩ current (I K ) and transient outward K ϩ (I A ) (Mei et al., 2004) . They are distinguishable by their activation and inactivation voltage ranges and kinetics and by their pharmacological sensitivities. In general, the functional roles of I A include influencing cell excitability and action-potential firing and controlling spike latency and repetitive firing (Shibata et al., 2000) . Recently, our own data indicated that apoptosis of cerebellar granule neurons induced by low K ϩ and free serum incubation is associated with an increase of I A (Hu et al., 2005 (Hu et al., , 2006 . Therefore, finding a new I A -channel modulator or modulated mechanism is highly useful for further investigations into neuron excitability, neuronal apoptosis, or neuronal protection.
Our recent studies demonstrated that the diphenyl structural NSAID, diclofenac, could activate I A in rat cerebellar granule cells as a novel voltage-dependent I A channel opener . In the present study, we used a whole-cell patch-clamping technique and small interfering RNA (siRNA) to investigate the effects of flufenamic acid on I A channels, as well as on their steady-state activation and steady-state inactivation. The results first demonstrate that flufenamic acid bidirectionally modulated the I A current of rat granule neurons at different concentrations and that two different mechanisms were involved.
Materials and Methods
Cell Culture. Cells were derived from cerebellum of 7-to 8-dayold Sprague-Dawley rat pups as described previously. Isolated cells then were plated onto 35-mm-diameter Petri dishes coated with poly-L-lysine (1 g/ml) at a density of 10 6 cells/ml. Cultured cells were incubated at 37°C with 5% CO 2 in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum, glutamine (5 mM), insulin (5 g/ml), KCl (25 mM), and 1% antibiotic-antimycotic solution. After culturing for 24 h, cytosine ␤-D-arabinofuranoside (5 M) was added to the culture medium to inhibit the proliferation of non-neuronal cells. All experiments were carried using cerebellar granule neurons at 5 to 7 days in culture.
Patch-Clamp Recordings. Whole-cell currents of granule neurons were recorded using a conventional patch-clamp technique. Before I A current recording, the culture medium was replaced with a bath solution containing 125 mM NaCl, 2.5 mM KCl, 10 mM HEPES, 1 mM MgCl 2 , 0.001 mM tetrodotoxin, and 20 mM tetraethylammonium (pH adjusted to 7.4 using NaOH). Soft glass recording pipettes were filled with an internal solution containing 135 mM sodium gluconate, 10 mM KCl, 10 mM HEPES, 1 mM CaCl 2 , 1 mM MgCl 2 , and 10 mM EGTA (pH adjusted to 7.3 using KOH). The pipette resistance is 6 to 7 M⍀ after filling with the internal solution. Flufenamic acid solutions were prepared extemporaneously and gravity ejected for 10 to 20 s from MSC-200 manual solution changer (Bio-Logic-Science Instruments, Grenoble, France). All recordings were performed at room temperature.
Data Acquisition and Analysis. All currents were recorded using an Axopatch 200B amplifier (Molecular Devices, Sunnyvale, CA) operated in voltage-clamp mode. Data acquisition and analysis were performed with pClamp 8.01 software (Molecular Devices) and/or Origin 6.1 (Microcal analysis software; OriginLab Corp., Northampton, MA). Statistical analysis was performed using the Student's t test with nonpaired comparison or paired comparisons where it is relevant. Values were given as means Ϯ S.E.M. with n as the number of cells tested. P value Ͻ 0.05 was used to denote the statistical difference between groups. When multiple comparisons were made, data were analyzed by a one-way ANOVA test.
siRNA Vector Construction. The oligonucleotides specifying the short-hairpin RNAs were designed via the website http://katahdin. cshl.org:9331/RNAi/html/rnai.html (Table 1) . For preparation of duplexes, 2 l of sense-stranded and antisense-stranded oligonucleotides (1 g/l each) were mixed together in 46 l of DNA annealing buffer (30 mM Hepes, 100 mM potassium acetate, and 2 mM magnesium acetate, adjusted to pH 7.4), heat-denatured at 90°C for 3 min, and annealed at 37°C for 1 h. Following this, 1 l of annealed DNA was ligated into 30 to 50 ng of BamHI/EcoRI restriction-digested, gel-purified siRNA vector (RNAi-Ready pSIREN-RetroQ; BD Biosciences Clontech, San Jose, CA) using phage T4 DNA ligase in a volume of 10 l. Several colonies were sequenced to select the correct one.
Transfection. The correct siRNA vectors were extracted using a QIAGEN (Valencia, CA) plasmid midi kit. The DNA concentration and purity were determined by measuring the absorbance at 260 and 280 nm. Ten microliters of Lipofectamine 2000 (Invitrogen, Carlsbad, CA) then was preincubated with 250 l of Opti-MEM I reduced serum medium (Gibco) at room temperature for 5 min. Meanwhile, the siRNA and pEGFP-F (BD Biosciences Clontech, Franklin Lakes, NJ) vectors (total, 4 g of plasmids) were diluted to 50 l with Opti-MEM I reduced serum medium (Invitrogen) at a ratio of 5:1 (v/v). Following this, the Lipofectamine 2000 and plasmid dilution were mixed and incubated at room temperature for 15 min. The DNA and Lipofectamine 2000 complexes were added to the 4-day-old granule cells that had been cultured in 1 ml of growth medium without antibiotics. After incubation for 5 h, the transfection medium was replaced with normal growth medium containing antibiotics. At 48 h after transfection, the cells with green fluorescence were further analyzed.
Chemicals. All drugs used were purchased from Sigma-Aldrich (St. Louis, MO), with the exception of the fetal calf serum. Dulbecco's modified Eagle's medium culture medium and antibiotic-antimycotic solution were obtained from Invitrogen. Flufenamic acid, diclofenac, mefenamic acid, indomethacin, and arachidonic acid were first dissolved in dimethyl sulfoxide (DMSO) and then diluted in extracellular or intracellular solution, with a final DMSO concentration Ͻ0.1%, which alone did not produce any modulation of I A .
Results
As rat cerebellar granule neurons display two main voltage-dependent outward K ϩ currents-the transient outward current (I A ) and the delayed rectifier current (I K )-we first identified whether flufenamic acid is specific for I A in the rat granule neurons. In the experiments carried out, the outward K ϩ currents were evoked by two sequential 200-ms depolarizing pulses to 40 mV at 1-s intervals, from holding potentials of Ϫ100 and Ϫ40 mV, respectively (Fig. 1A) . When the membrane potential was held at Ϫ100 mV, depolarizing voltage pulses elicited a global outward current (I A plus I K ) that activated rapidly (5-10 ms) and then decayed as time progressed. After 1-s intervals at a conditioning potential of Ϫ40 
Si, sense-stranded interference oligonucleotide; Ri, reverse-stranded interference oligonucleotide. mV, the same depolarizing step only evoked a slight inactivating or noninactivating outward K ϩ current that had been previously described as a delayed rectifier I K current. It is evident in Fig. 1a that flufenamic acid significantly (100 M) inhibited the early inactivating I A component that was elicited by depolarizing the pulse and then activating the later current that was evoked by the second depolarizing pulse. Flufenamic acid decreased the amplitude of I A from 2107.5 Ϯ 270 to 1859.6 Ϯ 263.7 pA (n ϭ 5, P Ͻ 0.05 using Student's t test), and by contrast, it increased the I K amplitude from 791.5 Ϯ 270 to 941.6 Ϯ 263.7 pA (n ϭ 5, P Ͻ 0.05 using the Student's t test). The effect of flufenamic acid on the amplitude of I A and I K was illustrated in Fig. 1B . In view of the fact that flufenamic acid was dissolved by 0.1% DMSO, we simultaneously examined the effect of DMSO on I A and I K . As shown in Fig. 1C , neither I A nor I K was modulated by 1% DMSO (n ϭ 5, P Ͼ 0.05, using Student's t test). In some cases, washout of flufenamic acid from the bath solution took a long time; the I A amplitude then recovered to a higher level than that of the control, suggesting that a lower concentration of flufenamic acid could augment I A (Fig. 1D ).
Therefore, we tested whether flufenamic acid inhibited I A in a concentration-dependent manner. To investigate merely the effect of flufenamic acid on I A , all the results described thereafter were obtained using a bath solution containing 20 mM tetraethylammonium to eliminate the I K currents. I A currents were then evoked by 200-ms constant depolarizing pulses, ranging from Ϫ100 mV to 40 mV at 10-s intervals. We unexpectedly found that application of flufenamic acid to the bath solution produced bidirectional modulation of current amplitude depending on the concentration used ( Fig. 2A) . At concentrations from 20 M to 1 mM, flufenamic acid significantly inhibited I A amplitude. The inhibitory effect of flufenamic acid on I A was fast and reversible following washing; application of flufenamic acid to the bath solution resulted in a clear, rapid decrease of current amplitude that reached its maximal effect within 30 to 60 s and returned to control levels after 1 to 2 min of washout. Moreover, the inhibition of I A is concentration-dependent. The inhibition of I A current by A, the original current traces recorded in the absence and presence of 100 M flufenamic acid (FFA). The current was evoked by two sequential 200-ms depolarizing pulses to 40 mV at 1-s intervals. The holding potentials were set to Ϫ100 mV (first pulse) for full activation of the I A , and at Ϫ40 mV (second pulse) for activation of the I K . B, I A and I K current recorded from the granule neuron; 1% DMSO was added to the bath solution. C, I A and I K current amplitude obtained from granule cells in the absence and presence of 100 M flufenamic acid. Each value is the mean Ϯ S.E.M. of five to six independent experiments. ‫,ء‬ P Ͻ 0.05 compared with control group. D, a sample in which washout of 100 M flufenamic acid from bath solution induced the augmentation of I A current amplitude. The current was elicited by a depolarizing pulse to 40 mV from the holding potentials of Ϫ100 mV. Flufenamic Acid Bidirectionally Modulated I A flufenamic acid at 50, 250, and 500 M and 1 mM was 24 Ϯ 5% (n ϭ 8), 27.3 Ϯ 3.8% (n ϭ 5), 44.6 Ϯ 5.8% (n ϭ 5), and 69.3 Ϯ 6.3% (n ϭ 3), respectively (P Ͻ 0.05, using a one-way ANOVA test). Interestingly, when reducing the concentration to 10, 1, and 0.1 M, flufenamic acid significantly and reversibly increased I A current amplitude to 143 Ϯ 8% (n ϭ 9), 119.5 Ϯ 3.7% (n ϭ 5), and 106.7 Ϯ 1.7% (n ϭ 4) of control, respectively (P Ͻ 0.05, using a one-way ANOVA test). Moreover, flufenamic acid activated I A current gradually and reached its maximal activation of I A within 2 to 3 min of drug application. Figure 2A illustrates typical experiments in which flufenamic acid was applied at different concentrations. The sum of bidirectional modulation on I A amplitude was demonstrated in Fig. 2B , which revealed that stimulatory or inhibitory effect of FA on I A current was dose-dependent.
The effect of flufenamic acid on the activation and inactivation properties of I A was studied using the appropriate voltage protocols. In the activation protocol, I A was evoked by a 200-ms depolarizing pulse from the first-pulse potential of Ϫ80 mV to ϩ20 mV in 10-mV steps at 10-s intervals (Fig. 3,  A and B) . When the peak current that was evoked from each command potential was normalized to the maximal current amplitude, we obtained an activation curve of I A . As shown in Fig. 3C , the activation curve was significantly shifted by the application of flufenamic acid (100 M); the current was half-activated at Ϫ17.7 Ϯ 1.4 and Ϫ7 Ϯ 2.4 mV in the absence and presence of flufenamic acid, respectively (n ϭ 6, P Ͻ 0.05), suggesting that flufenamic acid significantly changed the voltage-dependent steady-state activation properties of I A .
We then studied the effect of flufenamic acid on voltagedependent steady-state inactivation of I A . Currents were elicited using 1-s conditioning prepulses from Ϫ110 mV to various membrane potentials before a 200-ms test pulse of ϩ20 mV (Fig. 4, A and B) . The data obtained from Fig. 4A showed that, when conditioning prepulse applying at Ϫ90 mV, the flufenamic acid-induced inhibitory effect on I A was 26 Ϯ 5.5%. By contrast, when conditioning prepulse was at Ϫ60 mV, the inhibitory effect of flufenamic acid reduced to 3 Ϯ 3%. After normalizing each current peak to the maximal current amplitude obtained from the Ϫ110 mV prepulses as a function of the conditioning prepulse potential, we found that flufenamic acid modified the steady-state inactivation curve of I A . In five cells studied, the half-maximal inactivation voltage was Ϫ58.5 Ϯ 1.8 and Ϫ49.7 Ϯ 1.1 mV in the absence or presence of flufenamic acid, respectively (n ϭ 6, P Ͻ 0.05). Figure 4C shows the statistical results of an inactivation curve that has been shifted approximately 9 mV toward the depolarizing potential by the addition of flufenamic acid. These results suggest that flufenamic acid decreased the I A current by modifying the steady-state I Achannel activation and inactivation properties.
Previous studies have demonstrated that fenamates (niflumic and flufenamic acid) have more evidence of inhibition of K v 4.3, which was stably expressed in Chinese hamster ovary cells (Wang et al., 1997) . Our own studies showed, as assessed by quantitative RT-PCR, whole-cell recording, and (Fig. 5B) . As shown in Fig. 5B , the I A amplitude and shape were modulated distinctly after silencing the expression of K v 4.2, K v 4.3, or Kv1.1, respectively. However, silencing the expression of One-second conditioning prepulses from Ϫ110 to 0 mV in 10-mV increments were applied before the test pulse to 20 mV. The voltage protocol is shown below the current records. B, steady-state inactivation curves of I A plot in the absence or presence of flufenamic acid. The abscissa indicates conditioning prepulse potentials. C, the peak current amplitude normalized to the maximal current was plotted against the prepulse potential. Normalized current points were fitted with a Boltzmann function, showing that the application of flufenamic acid shifted the steady-state inactivation curve toward positive potential. The data represent the mean values Ϯ S.E.M. obtained from six cells. 1, the inhibition of the remaining I A current by flufenamic acid was 19.2 Ϯ 3.9% (n ϭ 9), 20.1 Ϯ 2.9% (n ϭ 9), and 27.0 Ϯ 5% (n ϭ 4), respectively. As shown in Fig. 5C , the inhibitory effect of flufenamic acid on the remaining current silencing of K v 4.2, K v 4.3, or K v 1.1 expression was similar to that of the normal I A channel current in the control (with empty vector, 20.8 Ϯ 5.8%). The results indicated that flufenamic acid modulated native I A channels of rat granule neurons rather than those of the K v 4.2, K v 4.3, and K v 1.1 subunits of the I A channel. However, the molecular target remains unknown.
To assess at what point flufenamic acid exerts its bidirectional effect on the I A channel, we tested whether the intracellular application of flufenamic acid could mimic the effect of the extracellular application of flufenamic acid on I A . When 10 M flufenamic acid was added to the pipette solution, we found that the current amplitude increased along with time after establishment of the whole-cell configuration and reached its maximal activation of I A within 3 to 5 min; these results were similar to those observed by extracellularly applying the lower concentration of flufenamic acid (Fig. 6A) . The percentage of current amplitude increase by intracellular 10 and 100 M flufenamic acid was 135 Ϯ 7% (n ϭ 6) and 132 Ϯ 5% (n ϭ 4), respectively (P Ͻ 0.05, using Student's t test). We then examined whether the intracellular application of flufenamic acid could modify the effect of flufenamic acid on I A induced by extracellular application. As Fig. 6B shows, after the current reached its maximal amplitude with 10 M flufenamic acid in the pipette solution, applying 100 M flufenamic acid extracellularly could still decrease the I A current amplitude. Figure 6C illustrates that, after I A was increased by intracellular application of flufenamic acid, flufenamic acid was applied extracellularly to reduce the current amplitude to 67 Ϯ 4% control, an inhibitory effect similar to that obtained without intracellular flufenamic acid (73 Ϯ 4% control). These results showed that flufenamic acid exerts its effects separately on the intracellular and extracellular side of I A channels.
As fenamates are the inhibitors of the cyclooxygenase, like all NSAIDs (Ouellet and Percival, 1995) , we tested whether I A activation was common to all NSAIDs by using three NSAIDs of different chemical groups (diclofenac, mefenamic acid, and indomethacin). All of the three NSAIDs can mimic the flufenamic acid-induced activatory effect on I A . The internal application of mefenamic acid (Fig. 7A) , diclofenac (Fig. 7B) , and indomethacin (Fig. 7C ) was performed by pipette solution, and the current amplitude increased after establishment of the whole-cell configuration and reached its maximum within 2 to 4 min. The percentage of current amplitude increased by intracellular methflunamic, indomethacin, and diclofenac was 145 Ϯ 7% (n ϭ 6), 130.2 Ϯ 3.6% (n ϭ 6), and 124.5 Ϯ 1.3% (n ϭ 6), respectively (P Ͻ 0.05, using Student's t test). Statistical analyses of the above data are shown in Fig. 7D .
Furthermore, the effects of eicosatetraynoic acid (ETYA) and arachidonic acid were tested to address whether increasing arachidonic acid and/or reducing its metabolic products were involved. Applying 10 M ETYA, which blocks the formation of active arachidonic acid metabolites, in the pipette solution mimicked the effect of flufenamic acid on I A (Fig. 8A) , and an average increase of I A current amplitude of 23 Ϯ 5% (n ϭ 5) was observed under these conditions. The effect of arachidonic acid was similar with ETYA, flufenamic acid, and other NSAIDs (Fig. 8B) . In the presence of intracellular arachidonic acid (10 M), the I A amplitude was augmented to 141 Ϯ 9%. We then observed whether the low concentration of flufenamic acid could still increase the I A amplitude, whereas arachidonic acid was used in the pipette solution. The result obtained from the four cells tested showed that, in the presence of intracellular arachidonic acid (10 M), the I A amplitude was augmented to 136 Ϯ 4%, and applying 10 M FA sequentially in the bash solution increased the I A current to 149 Ϯ 4% control (n ϭ 4), with an augmentation of 13.2 Ϯ 2.6% (Fig. 8C) . To avoid the effect of DMSO on I A , the intracellular solution with 1% DMSO was also tested as the control. The 1% DMSO alone did not produce any modulation of I A ; the percentage of current amplitude that increased as a result of intracellular 1% DMSO was 105 Ϯ 6%. There was no significant difference compared with the normal intracellular solution (n ϭ 5, P Ͼ 0.05, using Student's t test). Statistical analyses of the above data are shown in Fig. 8C .
Discussion
Our results first demonstrate that flufenamic acid bidirectionally modulated the I A current of rat granule neurons at different concentrations and via different methods of application; external application at concentrations beyond 10 M resulted in inhibiting I A , whereas external application or intracellular application of 10 M flufenamic acid augmented I A . Stimulatory or inhibitory effect of flufenamic acid on I A current was dose-dependent.
The mode by which fenamatic acids inhibited ion channels is uncertain. As diphenyl carboxylate and its derivates, including flufenamic acid, are highly lipophilic molecules; modifying membrane ion channels by them can result in alterations of the permeability of cell membranes (Ottolia and Toro, 1994) or a nonspecific lipid effect on the channels (Li et al., 1999; Bock et al., 2003) . In our study, the rapid onset and reversible inhibition induced by flufenamic acid suggested that its effects are probably mediated by a direct action on the channel and are not caused by indirect effects, such as lowering and/or increasing intracellular factors. The direct blocking effect on ion channels was similar to that in previous studies on rat supraoptic neurons and expressed systems in which flufenamic acid blocked the Ca 2ϩ -dependent nonselective cation channels and human K v 2.1 subunits stably expressed in the Chinese hamster ovary cells (Lee and Wang, 1999; Partridge and Valenzuela, 2000) . These results, together with our observations on I A channels, suggest that flufenamic acid, like other members of the fenamate acid class, have a broad spectrum of nonspecific actions on ionchannel proteins.
Transient potassium currents (I A ) have been described in neurons from many regions of the central nervous system and also in cardiac and vascular cells (Hoffman and Johnston, 1998; Song et al., 1998) . Comparisons with other voltage-gated K ϩ channels showed that I A significantly operates at subthreshold membrane potentials and transiently inactivates during depolarizing pulses. In the rat cerebellar granule cells, fenamate acid significantly shifted both the steady-state activation and steady-state inactivation curves toward a more depolarized potential. Moreover, a flufenamic acid-induced inhibitory effect on I A channels was seen at a hyperpolarizing potential at which few I A channels were inactivated. Thus, these results indicated that flufenamic acid might have a much more higher affinity for activated I A channels than for inactivated channels. Therefore, these results suggested that flufenamic acid not only decreased the current amplitude by blockading the I A channels but also modified the channel properties in terms of activation or inactivation gating. The latter function might involve modulation of neuronal excitability.
Recent reports have suggested that members of the shal (K v 4) family form the major components of the I A channels in the central nervous system (Serôdio and Rudy, 1998; . Shibata et al. (2000) reported that I A channels encoded by the K v 4 family were found in cerebellar neurons; moreover, our own results revealed that the majority of the I A channels were not only conducted by the K v 4 family but also by K v 1.1 in rat granule cells. As the previous study by Wang et al. (1997) showed, by using a heterologous expression system, fenamates (niflumic and flufenamic acid) more strongly inhibited K v 4.3 than K v 4.2. To identify whether the inhibitory effect induced by flufenamic acid on I A was associated with the unitary subunit of I A -channel protein, we tested the effect of flufenamic acid on the remaining current by silencing K v 4.2, K v 4.3, and K v 1.1, respectively. However, our results indicated that silencing the expression of any of the above subunits of the I A channel could not eliminate the effect of flufenamic acid on the I A current. Because there is a high degree of structural similarity between the K v 4.3 and K v 4.2 channels and the K v 4.3 channel is 75% identical to the K v 4.2 channel at the amino acid level (Dixon al., 1996) , these results suggested that the effects of flufenamic acid were probably not isoform-selective. The discrepancy between our observation and Wang et al. (1997) may result from the differences between the reconstituted K v 4.2 or K v 4.3 channel complex and the native I A channel of granule neurons; the latter consisted of K v 4 family and K v 1.1 subunits simultaneously.
It was surprising to find in our studies that when a lower concentration of flufenamic acid was used, it induced the activator effect on I A . This was the opposite of what happened at higher concentrations but similar to what happened when the drug was administered internally via patch pipettes. Moreover, intracellular application of flufenamic acid did not alter the inhibitory effect induced by extracellular application of flufenamic acid. Therefore, it is conceivable that flufenamic acid augmented I A via another mechanism other than the channel block. One possibility could be the inhibition of cyclooxygenase, as it has been well established that fenamates are also inhibitors of cyclooxygenase, as well as other NSAIDs (Wu, 1998 ). Therefore, we tested whether I A activation is common to all NSAIDs; three NSAIDs of different chemical groups (diclofenac, mefenamic acid, and indomethacin) were randomly chosen. All of the three NSAIDs could have mimicked the flufenamic acid-induced stimulatory effect on I A when they were applied internally by pipette solution. One possibility could be that the enzyme cyclooxygenase was inhibited, as it has been well established that fenamates are also inhibitors of the enzyme cyclooxygenase (Ouellet and Percival, 1995) . Thus, it is conceivable that a lower concentration or intracellular flufenamic acid-induced augmentation of I A was due to the modulatory effect of cyclooxygenase inhibition, whereas external application at higher concentrations of flufenamic acid decreased I A by the channel-blocking mechanism.
Inhibitors of the cyclooxygenase pathway in the arachidonic acid (AA) cascade can cause the buildup of AA and/or reduce its metabolic products (for a review, see Bazan, 2003) . By intercellular application of AA, we determined whether the fenamate acid-induced activation effect on I A was associated with accumulation of AA or its metabolic products. The observation that internal application of AA mimicked the effect of fenamate acid on I A is consistent with our hypothesis. To avoid the effect of DMSO on I A , which is a solvent of AA, we also tested the effect of AA dissolved in 0.1% ethanol and obtained the same results (data not shown). Thus, it indicated that AA could act as a mediator of I A channels, as reported first in smooth muscle (Ordway et al., 1989) . In addition, ETYA, which blocks the formation of active AA metabolites, mimicked the effect of AA activation on I A , indicating that AA activation was direct and not mediated by its oxygenated metabolites, as reported by Danthi et al. (2003) in bovine adrenal zona fasciculata cells. However, whether AA has a direct mediatory effect on I A channels or indirectly activates the downstream signal in granule neurons needs to be further explored.
Arachidonic acid and its metabolic products have been shown to modulate a large number of ligand-and voltagegated ion channels in a variety of systems (Ordway et al., 1991) . The modulator effects of AA and its metabolites either activate or inactivate ion channels depending on the cell types studied (Patel and Honore, 2001; Takahira et al., 2001; Wei et al., 2004) . However, it is noticeable that, in rat granule neurons, our study and Holmqvist et al. (2001) have revealed that extracellular application of AA remarkably inhibited I A amplitude and modulated its kinetics (Wang et al., 2005) . Moreover, molecular cloning showed that the AA-induced inhibition effect on I A occurs by acting directly on the K v 4-K ϩ channel interacting protein complex (Holmqvist et al., 2001) . Here, our results have revealed that, although AA was applied intracellularly, it evoked an opposite stimulatory effect on I A . To date, few investigations have used AA intracellularly, although the study in excised membrane patches (Kim et al., 1995) has shown that AA applied to the cytoplasmic or extracellular side of the membrane caused opening of three types of channels. We reason that the conflicting function of AA may result from its difference in binding location in cytoplasmic or extracellular sides of the membrane. Further work will be necessary to examine this possibility.
The overall properties of I A make it an excellent target for any modulatory mechanism influencing cell excitability and action-potential firing (Shibata et al., 2000; Kiss et al., 2002) . Although the reliable mechanism of fenamate acid-induced biodirected modulation of I A remains unknown, our results may partially account for the unwanted side effects of fenamate acid and might be a valuable new avenue to investigate in terms of therapeutic and/or basic research applications of NSAIDs.
